What Shots Do You Get at 16? Teen Vaccines Explained

The main vaccine specifically due at age 16 is the meningococcal ACWY booster, a second dose that builds on the first shot most teens received around age 11 or 12. But that single booster rarely stands alone at the visit. Depending on what a teenager has already received and what their doctor recommends, the appointment can also include a meningococcal B vaccine, an HPV catch-up dose, a flu shot, or a COVID-19 update. The 16-year-old checkup is a pivotal moment in the immunization schedule, and understanding what each shot does and why the timing matters can make the visit feel far less mysterious.

The Meningococcal ACWY Booster

The centerpiece of the age-16 vaccine visit is the meningococcal conjugate vaccine, often called MenACWY or MCV4. This protects against four serogroups of the bacterium that causes meningococcal disease, a rare but devastating infection that can progress from mild symptoms to life-threatening illness within hours. Most teens received their first dose at 11 or 12, and the booster at 16 is designed to extend protection through the late teens and early twenties, the years when exposure risk climbs sharply.

Why does risk go up? Meningococcal bacteria spread through close contact, and the transition into college dorms, shared housing, and active social life creates ideal conditions. A large study of U.S. college students found that freshmen living in dormitories had an incidence rate of 5.1 per 100,000, compared with 0.7 per 100,000 for undergraduates overall. On multivariable analysis, freshmen in dorms had roughly 3.6 times the odds of meningococcal disease compared with other college students.¹ The booster at 16 ensures that antibody levels are high right as many teens head into these higher-risk environments.

Research tracking meningococcal carriage among dormitory residents in South Korea illustrates how quickly the bacterium circulates in shared living. Carriage rates rose from about 3% at move-in to nearly 12% just three months later, with socializing at bars and clubs roughly tripling the odds of picking up the bacterium.² Most carriers never get sick themselves, but they can pass the bacteria to someone who does. The booster helps interrupt that chain.

Meningococcal B and the Shared Clinical Decision

The meningococcal ACWY vaccine does not cover serogroup B, which requires its own separate vaccine. Two serogroup B vaccines were licensed by the FDA for people aged 10 to 25: one as a three-dose series and another as a two-dose series.³ Unlike the ACWY booster, the meningococcal B vaccine is not a blanket recommendation for all teens. The Advisory Committee on Immunization Practices classifies it under “shared clinical decision-making,” meaning teens and their parents should discuss with a provider whether the vaccine makes sense for them.

The reason for this category distinction is partly about epidemiology and partly about the science behind the vaccine. Serogroup B’s outer capsule is poorly immunogenic, meaning it does not trigger a strong immune response the way serogroups A, C, W, and Y do. Vaccine developers spent decades identifying proteins on the bacterial surface that could reliably prompt protective antibodies.⁴ The resulting vaccines work, but because serogroup B disease is uncommon in the general teen population, health authorities opted for a softer recommendation rather than a universal mandate.

That said, certain teens face meaningfully elevated risk. Among college outbreaks of serogroup B, first-year undergraduates had nearly 12 times the incidence of non-undergraduates, and students involved in Greek life had about 10 times the risk compared with unaffiliated students.⁵ For teens heading into a college environment, especially those planning to live in dorms or join a fraternity or sorority, the conversation about meningococcal B is worth having before they leave home.

Catching Up on HPV and Tdap

The HPV vaccine is routinely recommended at 11 or 12, well before age 16. But many teenagers miss it or haven’t completed the full series. The 16-year-old visit is an important opportunity to catch up. HPV vaccination has demonstrated real-world effectiveness against HPV infection, cervical disease, and cervical cancer, with evidence of herd protection even among unvaccinated women in countries with high uptake.⁶ If your teen started the series but hasn’t finished, the 16-year checkup is the time to complete it. Teens who haven’t started at all can begin the series at this visit, though those who start after their 15th birthday need three doses instead of two.

The Tdap vaccine, which protects against tetanus, diphtheria, and pertussis (whooping cough), is another shot most teens receive at 11 or 12. If a 16-year-old somehow missed it, catching up is important. Tdap boosters were added to the adolescent schedule specifically because pertussis outbreaks were rising, and immunity from childhood vaccines wanes faster than people realize. Research modeling pertussis immunity found that an estimated 15% of vaccinated individuals lost protection within five years of their last dose.⁷ That rapid decline is exactly why an adolescent booster exists. Studies of the two FDA-licensed Tdap boosters have confirmed effectiveness against pertussis disease with a safety profile comparable to the older tetanus-diphtheria vaccine.⁸

Annual flu shots and updated COVID-19 vaccines may also be offered at a 16-year-old’s visit depending on the season and the teen’s vaccination history. These aren’t age-specific in the same way the meningococcal booster is, but they round out the visit.

What Side Effects to Expect

Teens and parents often worry most about what happens after the shots. The evidence is reassuring. In a large clinical trial of the meningococcal B vaccine in adolescents and young adults, the most commonly reported reaction was mild or moderate pain at the injection site.⁹ A study examining the side-effect profile of meningococcal B vaccination in children found that about 31% of doses produced some kind of local or systemic reaction. Of those, roughly 61% involved fever and 39% involved local symptoms like soreness or redness. Side effects were most common after the first dose and tended to be transient, clearing up within two to three days. No serious reactions like anaphylaxis or encephalopathy were observed.¹⁰

One side effect that doesn’t get enough attention is fainting, or more precisely, the lightheaded feeling that precedes it. Adolescents are more prone to post-vaccination presyncope (feeling faint) than younger children or adults. A randomized controlled trial tested a clinic-based intervention and found that presyncope occurred in 36% of the intervention group versus 48% of the control group, suggesting that simple measures like having teens sit or recline and using distraction techniques can make a real difference.¹¹ If your teen tends to feel woozy around needles, it’s worth mentioning this to the provider ahead of time. Most clinics will have the teen sit for 15 minutes after the shot as a precaution.

Getting Multiple Shots at the Same Visit

It’s common for a 16-year-old to receive two or even three vaccines in a single appointment, especially if they’re catching up on missed doses. Parents sometimes wonder whether stacking vaccines increases the risk of side effects. A systematic review of co-administration safety in people under 18 found that receiving three or more injectable vaccines in the same session did modestly raise the chance of experiencing any adverse event, with about 1.5 times the odds compared with fewer simultaneous shots. However, the risk of serious adverse events did not differ between groups.¹² In practical terms, this means a teen who gets three shots might have a slightly sorer arm or be a bit more tired that evening, but the chance of anything medically significant stays the same. There’s no immunological reason to space out the vaccines across multiple visits unless a specific medical condition warrants it.

School Requirements and Why They Matter

Many states require proof of the meningococcal ACWY booster for entry into 12th grade or for college enrollment, which is part of why 16 is such a key age. These school-entry mandates do more than just enforce compliance for one vaccine. A study in metropolitan Philadelphia found that after new school-entry requirements for Tdap and MenACWY were implemented, vaccination rates for those vaccines rose among younger adolescents, and among 17- to 18-year-olds there were also statistically significant increases in meningococcal B and HPV vaccination, neither of which were actually required by the new policy.¹³ In other words, the visit prompted by one required vaccine tends to bring other recommended vaccines along with it. The appointment itself is the intervention.

That insight matters because teen vaccination rates drop off steeply with age. Among commercially insured individuals, about 73% of 16-year-olds had a preventive visit in a given year, but by age 19 that dropped to 56%, and by 23 it was just 45%. The pattern was even steeper for Medicaid-insured teens, starting at about 54% at 16 and falling to 28% by 23.¹⁴ The 16-year-old checkup may be one of the last reliable touchpoints a teenager has with the healthcare system before they age out of routine pediatric care. Missing it means missed vaccines, potentially for years.

A targeted review of the literature identified four factors that consistently improve adolescent vaccination coverage: scheduling a dedicated well-child or preventive visit (rather than relying on sick visits), having the provider proactively bring up vaccines, educating providers about meningococcal disease and current recommendations, and state-level school-entry mandates.¹⁵ For parents, the takeaway is straightforward: schedule the visit, and let the doctor do the recommending. Provider recommendation alone substantially reduced hesitancy among parents who were on the fence about HPV vaccination, cutting their likelihood of being unsure by about 70%.¹⁶

Can a 16-Year-Old Consent to Their Own Vaccines

This question comes up more than you might expect, especially when a teen wants to get vaccinated but a parent is hesitant, or when a parent simply isn’t available at the appointment. The short answer is: it depends entirely on which state you live in. State laws on minor consent for vaccination vary widely. Most jurisdictions require parental consent for minors to receive vaccines, and only a handful of states explicitly let minors of any age consent to general medical care or immunizations on their own. The landscape is a patchwork of mature-minor doctrines, narrow exceptions for specific communicable diseases, and general consent statutes that leave adolescent vaccination rights legally inconsistent across the country.¹⁷

In practice, this means that a motivated 16-year-old in one state can walk into a pharmacy and get vaccinated independently, while a teen in the next state over needs a parent present or a signed consent form. If you’re a teen reading this and wondering whether you can get your shots on your own, the quickest route to an answer is calling your pediatrician’s office or local pharmacy and asking what your state allows. Some pharmacies also post their minor consent policies online.

A Pentavalent Vaccine on the Horizon

One of the most promising developments in teen vaccination is a pentavalent meningococcal vaccine that would combine protection against all five serogroups (A, B, C, W, and Y) into a single product. Right now, covering all five requires two separate vaccines with different schedules, which adds complexity, extra visits, and more needles. A combined vaccine could simplify things considerably.

Phase 3 trials of this pentavalent vaccine, called MenABCWY, have produced strong results. In one trial, the vaccine proved noninferior to the existing standalone MenACWY and MenB vaccines, with most teens and young adults achieving robust antibody responses against all targeted serogroups. Reactogenicity was mostly mild or moderate and transient.¹⁸ A separate large randomized trial confirmed that MenABCWY was noninferior to both the existing MenACWY conjugate vaccine and the MenB vaccine, with a breadth of immune response against serogroup B strains around 78% to 84% depending on the analysis method used. No safety concerns were identified.¹⁹

A third trial specifically looked at teens and young adults who had already received a MenACWY vaccine earlier in life, the exact population that would be getting their 16-year-old booster. After two doses of MenABCWY given six months apart, virtually all participants (99.5% to 100%) achieved strong antibody responses against serogroups A, C, W, and Y. For the serogroup B component, response rates ranged from about 76% to 96% depending on the strain tested, up from single-digit baselines.²⁰ If approved for routine use, this vaccine could turn what is currently a multi-vaccine conversation into a single, more straightforward recommendation, potentially boosting uptake of serogroup B coverage along the way.

Why the HPV Conversation Still Stalls

Of all the vaccines available to 16-year-olds, the HPV vaccine tends to generate the most parental hesitancy. A national survey found that safety concerns and side effects were the top reason for lack of intent to vaccinate among parents who were strongly or somewhat hesitant, cited by 30% and 20% of those groups respectively. But among parents who were simply unsure rather than opposed, the most common reason for not vaccinating was that no provider had recommended it, cited by 34%.¹⁶ That gap between hesitancy and simple lack of a nudge is striking. A large share of unvaccinated teens don’t have vaccine-refusing parents; they have parents who were never clearly told “your child should get this.” The evidence from Scotland’s national vaccination program showing real-world effectiveness against HPV infection, cervical disease, and cancer reinforces what providers can tell those parents when the conversation finally happens.⁶

If your teen is 16 and hasn’t started or finished the HPV series, don’t assume the window has closed. The vaccine is approved through age 26 and can be given alongside the meningococcal booster at the same visit. The 16-year-old checkup may be the most practical chance to get it done before routine medical visits become less frequent.